Last: | $17.70 |
---|---|
Change Percent: | 0.9% |
Open: | $17.56 |
Close: | $17.70 |
High: | $17.85 |
Low: | $17.35 |
Volume: | 78,215 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$17.7 | $17.56 | $17.7 | $17.85 | $17.35 | 78,215 | 03-28-2024 |
$17.72 | $17.45 | $17.72 | $17.97 | $17.4284 | 88,952 | 03-27-2024 |
$17.57 | $18.13 | $17.57 | $18.21 | $17.57 | 55,434 | 03-26-2024 |
$18.21 | $18.65 | $18.21 | $18.6996 | $18.05 | 56,621 | 03-25-2024 |
$18.78 | $19 | $18.78 | $19.3999 | $18.75 | 24,292 | 03-22-2024 |
$19.16 | $19.55 | $19.16 | $19.55 | $18.74 | 39,338 | 03-21-2024 |
$19.45 | $18.7 | $19.45 | $19.65 | $18.47 | 78,863 | 03-20-2024 |
$18.78 | $18.19 | $18.78 | $18.87 | $17.6279 | 70,823 | 03-19-2024 |
$18.27 | $17.5 | $18.27 | $18.76 | $17.5 | 34,788 | 03-18-2024 |
$17.52 | $17.52 | $17.52 | $17.9 | $17.4408 | 48,667 | 03-15-2024 |
$17.37 | $17.64 | $17.37 | $17.86 | $17.19 | 31,428 | 03-14-2024 |
$17.79 | $17.85 | $17.79 | $18.1073 | $17.52 | 38,360 | 03-13-2024 |
$17.84 | $18.28 | $17.84 | $18.28 | $17.58 | 30,770 | 03-12-2024 |
$18.13 | $18.27 | $18.13 | $18.28 | $17.82 | 38,001 | 03-11-2024 |
$18.27 | $18.45 | $18.27 | $18.635 | $18.2 | 20,989 | 03-08-2024 |
$18.42 | $18.08 | $18.42 | $18.7491 | $17.8443 | 28,612 | 03-07-2024 |
$18.07 | $17.28 | $18.07 | $18.14 | $17.1865 | 73,581 | 03-06-2024 |
$17.13 | $17.25 | $17.13 | $17.29 | $16.68 | 105,111 | 03-05-2024 |
$17.2 | $17.1 | $17.2 | $17.425 | $16.69 | 84,068 | 03-04-2024 |
$17.15 | $17.41 | $17.15 | $17.5899 | $17.01 | 43,126 | 03-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that U.S. FDA has informed the company that following additional consideration the available clinical data from its Phas...
2024-03-24 08:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-14 06:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...